Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5145143 | 0.93 | — | — | |
| SCHEMBL2029504 | 0.85 | IMPDH2 (0.33) | CA1CA2CA4CA6 | |
| SCHEMBL13866596 | 0.83 | CA2 (0.31) | CA2CA4 | |
| SCHEMBL4476507 | 0.82 | TDP1 (0.32) | — | |
| SCHEMBL14392684 | 0.82 | — | — | |
| SCHEMBL14458460 | 0.80 | IMPDH2 (0.33) | CA1CA2CA4CA6 | |
| SCHEMBL5610705 | 0.78 | — | — | |
| SCHEMBL28799273 | 0.78 | IGF1R (0.35) | — | |
| SCHEMBL10748647 | 0.77 | CA1 (0.31) | CA1CA2CA4CA6 | |
| SCHEMBL7971157 | 0.75 | CA2 (0.46) | CA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080039642-A1 | Practical, Cost-Effective Synthesis of Chloromethylated 1, 4-Benzoquinones | ZYMES, LLC | 2008-02-14 | — | — | US | disclosed |
| WO-2006032425-A2 | A PRACTICAL, COST-EFFECTIVE SYNTHESIS OF CHLOROMETHYLATED 1,4-BENZOQUINONES | ZYMES, LLC (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1640355-A1 | A practical, cost-effective synthesis of chloromethylated 1,4- benzoquinones | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039642-A1 | Practical, Cost-Effective Synthesis of Chloromethylated 1, 4-Benzoquinones | NDUFA10, NDUFB10, NDUFA5 | CA1 3987/4885CA2 2696/4885CA4 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.